About Pharmagreen Biotech, Inc. and WFS Pharmagreen Inc.
WFS Pharmagreen Inc. is a wholly owned Canadian based subsidiary of Pharmagreen Biotech, Inc., a publicly traded (OTC PINKS: PHBI) company. WFS Pharmagreen Inc. is a cannabis company that is becoming the largest producer of cannabis plantlets through a proprietary tissue culture process with opportunity to become one of the largest players globally. Pharmagreens’ mission is to advance the technology of tissue culture science and to provide the highest quality 100% germ free, disease free and all genetically the same plantlets of cannabis and other flora while offering full spectrum DNA testing for plant identification, live genetics preservation using low temperature storage for various cannabis and horticulture plants; extraction of botanical oils mainly CBD oil, and to deliver laboratory based services to the North American Cannabis and agriculture sectors. For further information on the company progress on the construction of a 63,000 square foot “Cannabis Biotech Complex” please visit www.pharmagreen.ca
CEO of Pharamagreen Biotech
47,860 Float https://www.otcmarkets.com/stock/PHBI/security Radio Interview
Oct 19, 2018 Radio interview with the CEO of Alliance Growers Dennis Petke. Petke speaks of his company’s relationship with Pharamagreen and Pharamagreen’s CEO Peter Wojick
First 20 minutes has the most info where Dennis Petke speaks on the faculty that Peter Wojcik and Pharamagreen is building, and Alliance part in it
Just a note: Dennis Petke is the CEO of Alliance that is buying a 30% stake in the Cannabis Biotech Tissue Complex
Peter Wojcik is the CEO of Pharamagreen who owns the majority stake of 70% in the Cannabis Biotech Tissue Complex https://www.spreaker.com/user/lifestyle_radio/the-b420-radio-show-live-with-guest-denn
Oct 26, 2018 Radio interview with the CEO of Pharamagreen Peter Wojcik and the CEO of Alliance Growers Dennis Petke
First 20 minutes Pharamagreen’s CEO Peter Wojcik speaks in details of the process of the tissue culture and Cannabis Complex.
At about 33:30 Peter Wojcik is asked a question and goes into a little bit about the future of Pharamagreen. Peter states an S-1 will be filed in Dec of 2018, and plans to move to QB and then move to NASDAQ. https://www.spreaker.com/user/lifestyle_radio/the-420-radio-show-with-guests-dennis-pe
Pharmagreen Begins Site Work for the Cannabis Biotech Tissue Culture Complex
Press Release | 11/05/2018
Pharmagreen Receives Final Board Approval From Regional Government to Apply for the Development Permit for its Cannabis Biotech Tissue Culture Complex Project
Press Release | 10/01/2018
Update: Pharmagreen Receives Green Light From Regional Government Services Committee for its Biotech Tissue Culture Complex Project
Press Release | 09/10/2018
Pharmagreen's Tissue Culture Revenue Model
Press Release | 08/14/2018
Confirmation of Change in Yearend
Press Release | 08/08/2018
Pharmagreen Biotech, Inc. Strategic Relationship with Alliance Growers Inc.
Press Release | 07/26/2018
Pharmagreen Cannabis Biotech Complex Update
Press Release | 07/16/2018
About Pharmagreen Biotech Inc. and WFS Pharmagreen Inc.
Press Release | 07/09/2018
Pharmagreen Biotech Inc. (f/k/a Air Transport Group Holdings, Inc.) Update
Press Release | 07/03/2018